16 Background 17 Depression is a serious mental health problem in different parts of the world and has been reported 18 to be rising among undergraduate medical students. The incidence of depression has not only been 19 linked to psychosocial factors but also to biological factors, such as altered urinary levels of 20 norepinephrine. This study was carried out to determine the prevalence of depression among 21 undergraduate medical students in Uganda and examine the relationship between depressive 22 symptoms and 24-hour urinary norepinephrine excretion levels in the participants. 23 Methods 24 One hundred and sixteen undergraduate medical students (75 males and 41 females) of Kampala 25 International University, in southwestern Uganda were evaluated for depression using the 21-item 26 Beck Depression Inventory-II (BDI) questionnaire. Twenty-four-hour urine collections from each 27 participant were assayed for norepinephrine excretion levels. Descriptive statistics and Pearson 28 correlation coefficient were computed to examine the data obtained.
7 112 to choose an option for each question that best described their feelings over the preceding week.
113 Responses to the 21 items were summed up to give their depressive status on a 4-point scale 114 giving a maximum score of 63. Participants with BDI score of 0-9 were categorized as normal, 115 scores of 10-18 were indicative of mild mood disturbance, scores of 19-29 were indicative of 116 moderate depression, scores of 30-40 were indicative of severe depression and those with score 117 of 40 and over were categorized as having very severe depression.
118
The prevalence of suicide ideation was measured with a frequency count of "yes" 119 response to each of the following questions: a) Have you ever experienced suicide thoughts 120 along with the wish to end your life by suicide? b) Did you experience suicide thoughts along 121 with the wish to end your life by suicide last week? The participants found to have depressive 122 symptoms or suicide ideation were instructed to discuss these symptoms with a physician for 123 further evaluation and treatment.
124 24-hour urine collection 125 Participants were provided with 3-liter opaque collection jugs containing a preservative (10 ml 126 of 6N hydrochloric acid, pH < 3.5) and a smaller 100 ml specimen bottles containing no 127 preservative. The 3-litre collection jug was labelled with a code similar to that of the BDI and 128 questionnaire earlier completed by the participant. To ensure urine collection during a typical 129 day under typical conditions, the participants were asked to collect urine in their residential 130 environment during a 24-h period.
131
They were instructed to collect all urine passed during the target period (Saturday to 132 Sunday when there are no scheduled lectures or university activities). The collection of the 24-h 133 urine started with the participant voiding (completely emptying bladder) and discarding the first 134 urine passed on Saturday morning. Thereafter, they were instructed to collect all of the urine 135 passed during that day and night including urine passed during bowel movements, up to and 136 including the first voiding of the following day (Sunday). Each urine sample was first collected 137 into the smaller container for ease of convenience and immediately transferred into the 3-litre 138 collection jug containing preservative. The participants were asked to keep the urine collection 139 jug tightly closed and refrigerated or kept in a cool place throughout the collection period. No 140 dietary restrictions were enforced; however, participants were advised to discontinue taking all 141 medications for an interval of at least 12 hours preceding the urine collection period.
142
To ensure compliance with the collection protocol, mobile phone numbers of every five 143 participants were assigned to a research assistant who sent four reminder messages at different 144 times within the 24-h period to continue with collection and to verifying that the urine jugs were 145 properly stored. If it was discovered that, a participant did not adhere to the collection protocol or 146 if the volume collected was less than 1 litre, the participant was asked to repeat the collection the 147 following weekend. In the laboratory, the volume of cumulative 24-h urine samples was recorded 148 and stirred thoroughly, separated into 10 ml aliquots in a sterile sample bottles, and then stored in 149 the laboratory refrigerator prior to analysis.
Measurement of 24-hour urinary norepinephrine
151 Quantitative measurement of NE in each urine sample was performed by enzyme immunoassay 152 (EIA) following a protocol described in detail by the manufacturer of the assay kit (Abnova, UK). 
Sample pre-treatment
158 An aliquot (10 µl) of working standard and 10 µl of urine samples were added to borate-coated 159 wells of a macrotiter plate. To these, 250 µl of double distilled deionised water was added. 50µl
160 of assay and extraction buffer (0.1 mol/L Tris-HCL buffer, 0.7 mol/L NaCl, 0.1 mol/L EDTA, 161 0.3 mmol/L Na 2 S 2 O 5 , pH 9.3) were added to each well of the plate respectively. The plates were 162 covered with adhesive foil and incubated for 30 min at room temperature on a shaker (approx.
163 600 rpm) after which the plates were emptied and blotted dry by taping the inverted plate on 164 absorbent material. Thereafter, 150 µl of acylation buffer was added to the wells respectively.
165 The plates were incubated for further 15 min at room temperature on a shaker (approx. 600 166 rpm). Wash buffer (1 mL) was pipetted into the wells and the plates incubated for 10 min at 167 room temperature on a shaker (approx. 600 rpm). 150 µl of hydrochloric acid was added into 168 the wells and the plates were covered with adhesive foil. The plates were further incubated for 169 10 min at room temperature on a shaker (approx. 600 rpm) after which the foil was discarded 170 and 20 µl of the supernatant was removed for subsequent norepinephrine EIA.
171

Enzyme Immunoassay
172 The enzyme solution (25 µl) was added into all wells of the NE microtiter strips followed by the 173 addition of 20 µl of the extracted standards and urine samples into the appropriate wells. The 174 solution was incubated at 37 °C for 30 min on a shaker. NE antiserum (50 µl) was added to the 175 wells and covered with adhesive foil. The preparation was further incubated for 2 hours at room 176 temperature on a shaker (approx. 600 rpm). Thereafter, the foil was removed and the content of Table 3 . The analysis did not indicate significant differences in 245 participants with depressive symptoms when compared to those without symptoms of 246 depression in relation to gender (X 2 = 1.011, df = 1, p = 0.315), age (X 2 = 1.974, df = 3, p = 247 0.578), type of residence (X 2 = 1.376, df = 2, p = 0.307), type of financial support (X 2 = 1.818, 248 df = 4, p = 0.769) and family type (X 2 = 0.219, df = 1, p = 0.640). However, there was a weak 249 and significant association of depressive symptoms with marital status (X 2 = 7.418, df = 3, p = 250 0.058) and the thoughts of committing suicide (X 2 = 17.005, df = 1, p = 0.0003); and relationship 251 with parents (X 2 = 7.042, df = 2, p = 0.0296) respectively. 266 g/day) respectively (Fig 3) . 281 To the best of our knowledge, this is the first study to estimate the prevalence of depression and 282 examine the association with socio-demographic and biological determinants of the disease among 283 undergraduate medical students in Uganda. Only one previous study has determined the prevalence 284 of depression among university students in Uganda without examining the underlying cause of the 285 observed rate of depression [12] . The results of our study indicated that, 28.4% and 14.4% of 286 undergraduate medical students of Kampala International University, Uganda, exhibited 287 depressive symptoms and suicide ideation respectively. No significant changes in mean depression 288 scores were observed among male and female participants even though prevalence was slightly 289 higher in males. The participants with depressive symptoms were more likely than those without 290 symptoms to have increased levels of 24-h mean NE excretion above the normal range (<90 291 µg/day).
292
The rate of depression of 28.4% is much higher than the 16.24% reported earlier among 293 the first-year students of Makerere University Kampala, Uganda [12] but closely aligned with the 294 results obtained from meta-analysis of 195 studies involving 129,123 medical students in 47 295 countries which demonstrated that 27.2% of medical students (range, 9.3% -55.9%) screened 296 positive for depression and that 11.1% (range, 7.4% -24.2%) reported suicidal ideation [31] . The 297 prevalence of depression and percentage of individuals with suicide ideation observed in this study 298 is concerning given that the development of depression and suicidality has been linked to an 299 increased short-term risk of suicide as well as a higher long-term risk of future depressive episodes 300 and morbidity [32, 33] . Also, depressive and suicidal symptoms in medical trainees may adversely 301 affect the long-term health of physicians as well as the quality of care [34] .
302
The concept that depression can be caused only by psychosocial or biological factors have 303 been suggested but their causal links still remain unclear. We found that depression rates were 304 higher among students within the age group of 20 -29 years (21.6%), those renting a room/house 305 outside the university (23.3%), those who are full-time students (20.7%), those whose financial 306 support comes from relatives (12.9%), and surprisingly those who claimed to have good quality
